EE04515B1 - Atsetlkoliinkoostiste stabiliseerimise meetodidja koostised - Google Patents

Atsetlkoliinkoostiste stabiliseerimise meetodidja koostised

Info

Publication number
EE04515B1
EE04515B1 EEP200000625A EEP200000625A EE04515B1 EE 04515 B1 EE04515 B1 EE 04515B1 EE P200000625 A EEP200000625 A EE P200000625A EE P200000625 A EEP200000625 A EE P200000625A EE 04515 B1 EE04515 B1 EE 04515B1
Authority
EE
Estonia
Prior art keywords
acetylcholine
buffered
acetolactic
stabilizing
compositions
Prior art date
Application number
EEP200000625A
Other languages
English (en)
Estonian (et)
Inventor
Tsao Fu-Pao
Edward Minno George
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of EE200000625A publication Critical patent/EE200000625A/xx
Publication of EE04515B1 publication Critical patent/EE04515B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polymerisation Methods In General (AREA)
EEP200000625A 1998-04-29 1999-04-27 Atsetlkoliinkoostiste stabiliseerimise meetodidja koostised EE04515B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6955298A 1998-04-29 1998-04-29
PCT/EP1999/002846 WO1999055304A1 (en) 1998-04-29 1999-04-27 Methods and compositions for stabilizing acetylcholine compositions

Publications (2)

Publication Number Publication Date
EE200000625A EE200000625A (et) 2002-02-15
EE04515B1 true EE04515B1 (et) 2005-08-15

Family

ID=22089751

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000625A EE04515B1 (et) 1998-04-29 1999-04-27 Atsetlkoliinkoostiste stabiliseerimise meetodidja koostised

Country Status (24)

Country Link
US (1) US6261546B1 (de)
EP (1) EP1073413B1 (de)
JP (1) JP2002512945A (de)
KR (1) KR100617429B1 (de)
CN (1) CN1147289C (de)
AT (1) ATE286380T1 (de)
AU (1) AU745124B2 (de)
BR (1) BR9910077A (de)
CA (1) CA2327398C (de)
CZ (1) CZ301969B6 (de)
DE (1) DE69923063T2 (de)
EE (1) EE04515B1 (de)
ES (1) ES2235486T3 (de)
HU (1) HU226104B1 (de)
ID (1) ID26032A (de)
IL (1) IL138775A0 (de)
NO (1) NO20005372D0 (de)
NZ (1) NZ507074A (de)
PL (1) PL194092B1 (de)
PT (1) PT1073413E (de)
RU (1) RU2225199C2 (de)
SI (1) SI1073413T1 (de)
UA (1) UA72209C2 (de)
WO (1) WO1999055304A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101595108A (zh) * 2006-11-30 2009-12-02 日本医事物理股份有限公司 对淀粉状蛋白具有亲和性的新化合物
US20130029919A1 (en) * 2011-07-26 2013-01-31 Allergan, Inc. Two part formulation system for opthalmic delivery

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5009892A (en) * 1989-03-03 1991-04-23 Mckinzie James W Rapid miosis with control of intraocular pressure
RU2056821C1 (ru) * 1993-02-26 1996-03-27 Межотраслевой научно-технический комплекс "Микрохирургия глаза" Глазные капли "кератоник"
RU2100020C1 (ru) * 1993-06-23 1997-12-27 Лейрас Ой Средство для местного лечения глазной гипертензии и глаукомы и способ его получения
US5565188A (en) 1995-02-24 1996-10-15 Nanosystems L.L.C. Polyalkylene block copolymers as surface modifiers for nanoparticles
US5612027A (en) 1995-04-18 1997-03-18 Galin; Miles A. Controlled release of miotic and mydriatic drugs in the anterior chamber

Also Published As

Publication number Publication date
CN1147289C (zh) 2004-04-28
JP2002512945A (ja) 2002-05-08
CA2327398C (en) 2008-12-30
PT1073413E (pt) 2005-04-29
US6261546B1 (en) 2001-07-17
NO20005372L (no) 2000-10-25
EP1073413B1 (de) 2005-01-05
HUP0100613A3 (en) 2001-12-28
KR100617429B1 (ko) 2006-08-30
CA2327398A1 (en) 1999-11-04
CN1298295A (zh) 2001-06-06
EP1073413A1 (de) 2001-02-07
DE69923063D1 (de) 2005-02-10
AU4034099A (en) 1999-11-16
WO1999055304A1 (en) 1999-11-04
CZ20003961A3 (cs) 2001-01-17
ATE286380T1 (de) 2005-01-15
AU745124B2 (en) 2002-03-14
ES2235486T3 (es) 2005-07-01
IL138775A0 (en) 2001-10-31
SI1073413T1 (de) 2005-08-31
ID26032A (id) 2000-11-16
RU2225199C2 (ru) 2004-03-10
NZ507074A (en) 2004-02-27
HUP0100613A2 (hu) 2001-08-28
NO20005372D0 (no) 2000-10-25
HU226104B1 (en) 2008-04-28
BR9910077A (pt) 2000-12-26
PL343174A1 (en) 2001-07-30
DE69923063T2 (de) 2005-12-22
UA72209C2 (en) 2005-02-15
PL194092B1 (pl) 2007-04-30
CZ301969B6 (cs) 2010-08-18
HK1034204A1 (en) 2001-10-19
EE200000625A (et) 2002-02-15
KR20010043121A (ko) 2001-05-25

Similar Documents

Publication Publication Date Title
PT1311285E (pt) Composicao farmaceutica liquida contendo um derivado de eritropoietina
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
MX9602818A (es) Un metodo de tratamiento de infeccion parasitaria usando antagonistas ige.
PL326203A1 (en) (methylsulphonyl)phenyl-2-(5)-furanones as cox-2 inhibitors
NO308798B1 (no) Proteinkinase-C-hemmere, anvendelse av samme for fremstilling av farmasøytika samt farmasøytisk formulering omfattende samme
DK0548114T5 (da) Mometason-furoat-monohydrat, fremgangsmåde til fremtilling deraf og farmaceutiske præparater indeholdende dette
ATE216590T1 (de) Arzneimittelformulierungen für il-12
DK1273299T3 (da) Minoxidilinindeholdende praparater
NO306295B1 (no) Heterosykliske forbindelser, farmasöytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene til fremstilling av medikamenter
YU78202A (sh) Tečne formulacije
JO1696B1 (en) Acetamide derivatives
WO2002028829A3 (en) Peptide deformylase inhibitors
AU6469401A (en) Pharmaceutically active compounds and methods of use
ES2111272T3 (es) Mezclas herbicidas.
PT1235579E (pt) Composicoes farmaceuticas contendo trimegestona
EE04515B1 (et) Atsetlkoliinkoostiste stabiliseerimise meetodidja koostised
DE69808475D1 (de) Aminosäurederivate zur behandlung von schlaganfall
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
HUP9603489A2 (hu) Gyógyszerkészítmény és eljárás előállítására
AU7525398A (en) Inhibitors for urokinase receptor
RU94046300A (ru) Химические соединения, способ их получения, фармкомпозиция, способ лечения, промежуточный продукт
DE69626544D1 (de) Arzneistoffe
ATE106883T1 (de) Azelastin-embonat, verfahren zu seiner herstellung und pharmazeutische zubereitungen, die als wirkstoff azelastin-embonat enthalten.
DK0817643T3 (da) Forbindelser og præparater til administration af aktive midler

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20110427